ILYANG PHARMACEUTICAL CO.,LTD
Develops & manufactures drugs, vaccines & supplements for oncology & gastroenterology needs.
007570 | KO
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- South Korea
- Address:
- 경기도 용인시 기흥구 하갈로 110, 용인시
- Website:
- https://www.ilyang.co.kr
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Founded in 1946, Ilyang Pharmaceutical is a research-driven company focused on the development and manufacturing of pharmaceutical products. The company's portfolio includes a wide range of prescription drugs, over-the-counter medications, vaccines, and health supplements. It has developed key products in therapeutic areas such as oncology, gastroenterology, and circulatory system disorders. Notable developments include Supect®, a new chemical entity for the treatment of leukemia, and Noltec®, an anti-ulcer agent. Ilyang emphasizes high-quality production through advanced manufacturing facilities and a commitment to innovation in addressing global health needs.
This is a Fraction of the Available Data.
You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for ILYANG PHARMACEUTICAL CO.,LTD and 9,000+ other companies.
Stop analyzing yesterday's news. Start building a real-time advantage.
Request Enterprise API AccessFilings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-09-11 00:00 |
Legal Proceedings Report
회계처리기준위반에따른검찰고발등조치
|
Korean | 7.0 KB | |
| 2025-09-11 00:00 |
Legal Proceedings Report
기타시장안내 (상장적격성 실질심사 사유 발생)
|
Korean | 4.9 KB | |
| 2025-09-11 00:00 |
Legal Proceedings Report
[기재정정]기타시장안내 (상장적격성 실질심사 사유 발생)
|
Korean | 8.2 KB | |
| 2025-09-10 00:00 |
Regulatory News Service
매매거래정지및정지해제(풍문등조회공시)
|
Korean | 5.1 KB | |
| 2025-09-10 00:00 |
Legal Proceedings Report
조회공시요구(풍문또는보도)
|
Korean | 3.5 KB | |
| 2025-09-05 00:00 |
Regulatory News Service
[기재정정]단일판매ㆍ공급계약체결
|
Korean | 13.1 KB | |
| 2025-08-18 00:00 |
Transaction in Own Shares
주요사항보고서(자기주식취득신탁계약해지결정)
|
Korean | 27.7 KB | |
| 2025-08-18 00:00 |
Transaction in Own Shares
신탁계약해지결과보고서
|
Korean | 19.8 KB | |
| 2025-08-14 00:00 |
Interim Report
반기보고서 (2025.06)
|
Korean | 1.6 MB |
Automate Your Workflow. Get a real-time feed of all ILYANG PHARMACEUTICAL CO.,LTD filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for ILYANG PHARMACEUTICAL CO.,LTD via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
